Synchrony(SYF)
Search documents
Synchrony's CareCredit and Daybreak Partner to Provide Better Sleep for Americans
Prnewswire· 2024-12-03 14:00
CareCredit health and wellness credit card now accepted as a payment option for Daybreak's sleep testing-kits and sleep apnea deviceSTAMFORD, Conn., Dec. 3, 2024 /PRNewswire/ -- Synchrony (NYSE: SYF), a premier consumer financial services company, and Daybreak, a top-provider of full at-home sleep testing kits and custom-fit sleep apnea devices, have extended flexible financing to customers interested in Daybreak's products. With an estimated 50-70 million Americans currently living with ongoing sleep disor ...
Synchrony to Participate in the 2024 Goldman Sachs Financial Services Conference
Prnewswire· 2024-12-03 13:00
STAMFORD, Conn., Dec. 3, 2024 /PRNewswire/ -- Synchrony (NYSE: SYF) President and Chief Executive Officer, Brian D. Doubles, and Chief Financial Officer, Brian J. Wenzel, will participate in a fireside chat at the 2024 Goldman Sachs Financial Services Conference on Tuesday, December 10, 2024 at 8:00 a.m. (Eastern Time).A live webcast and replay will be made available on the Synchrony Investor Relations website at www.investors.synchrony.com. About SynchronySynchrony (NYSE: SYF) is a premier consumer financi ...
Synchrony (SYF) Is Up 1.87% in One Week: What You Should Know
ZACKS· 2024-11-22 18:00
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...
Synchrony (SYF) Up 14.4% Since Last Earnings Report: Can It Continue?
ZACKS· 2024-11-15 17:36
Core Viewpoint - Synchrony reported strong Q3 2024 earnings, driven by effective expense management and a growing loan receivables portfolio, leading to a positive outlook for the company despite some challenges in consumer spending [2][3][21] Financial Performance - Adjusted earnings per share (EPS) for Q3 2024 were $1.94, exceeding the Zacks Consensus Estimate of $1.77 and up from $1.48 a year ago [2] - Net interest income rose 5.7% year over year to $4.6 billion, surpassing the consensus mark by 2.1% [2] - Total loan receivables increased 4% year over year to $102.2 billion, although it fell short of the consensus estimate of $103.3 billion [4] - Total deposits grew 5.4% year over year to $82.3 billion, but also missed estimates [5] Expense Management - Total other expenses increased 3% year over year to $1.19 billion, remaining below the estimate of $1.21 billion [7] - The efficiency ratio improved by 200 basis points year over year to 31.2%, which is below the consensus mark of 32.78% [7] Loan and Purchase Volume - Purchase volume declined 4% year over year to $45 billion due to selective consumer spending and credit actions, missing the consensus estimate of $46.5 billion [5] - New accounts decreased by 18% year over year to 4.7 million, while average active accounts remained stable at 70.4 million [6] Capital Deployment - Synchrony returned $300 million through share buybacks and paid $99 million in common stock dividends during Q3 2024, with a remaining buyback capacity of $700 million [15] Guidance and Outlook - For 2024, Synchrony expects EPS in the range of $8.45-$8.55, up from the previous estimate of $7.60-$7.80, reflecting a positive adjustment from the 2023 level of $5.19 [16] - The company anticipates low single-digit decreases in purchase volumes and loan receivables growth for Q4, with net interest income expected to remain flat sequentially [17] - The net charge-off rate is expected to be lower in the second half of the year compared to the first half [18] Market Sentiment - There has been a notable upward trend in consensus estimates, with a shift of 43.7% in the past month, indicating positive investor sentiment [19] - Synchrony holds a Zacks Rank 1 (Strong Buy), suggesting expectations for above-average returns in the coming months [21]
Are You Looking for a Top Momentum Pick? Why Synchrony (SYF) is a Great Choice
ZACKS· 2024-11-06 18:00
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for moment ...
SYF vs. BAM: Which Stock Is the Better Value Option?
ZACKS· 2024-11-06 17:45
Core Viewpoint - The comparison between Synchrony (SYF) and Brookfield Asset Management (BAM) indicates that SYF currently offers better value for investors based on various financial metrics and analyst outlooks [1][3][7]. Valuation Metrics - SYF has a forward P/E ratio of 8.84, significantly lower than BAM's forward P/E of 38.79, suggesting that SYF is more attractively priced [5]. - The PEG ratio for SYF is 1.10, while BAM's PEG ratio stands at 2.66, indicating that SYF has a better balance between its price and expected earnings growth [5]. - SYF's P/B ratio is 1.50, compared to BAM's P/B of 7.60, further highlighting SYF's relative undervaluation [6]. Analyst Outlook - SYF holds a Zacks Rank of 1 (Strong Buy), reflecting stronger earnings estimate revision activity compared to BAM, which has a Zacks Rank of 3 (Hold) [3][7]. - The improving analyst outlook for SYF suggests a more favorable investment environment for value investors [3][7]. Value Grades - SYF has received a Value grade of A, while BAM has a Value grade of D, indicating a significant difference in perceived value between the two stocks [6].
Fast-paced Momentum Stock Synchrony (SYF) Is Still Trading at a Bargain
ZACKS· 2024-11-06 14:51
Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point for fast-moving stocks, which can lead to limited upside or downside risks [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [3] Group 2: Synchrony (SYF) Stock Analysis - Synchrony (SYF) has shown a price increase of 11% over the past four weeks, indicating growing investor interest [4] - Over the past 12 weeks, SYF's stock has gained 24.2%, with a beta of 1.59, suggesting it moves 59% more than the market [5] - SYF has a Momentum Score of B, indicating a favorable time to invest based on momentum [6] Group 3: Earnings Estimates and Valuation - SYF has received upward revisions in earnings estimates, earning a Zacks Rank 1 (Strong Buy), which is associated with strong momentum effects [7] - The stock is currently trading at a Price-to-Sales ratio of 0.98, suggesting it is undervalued as investors pay only 98 cents for each dollar of sales [7] Group 4: Additional Investment Opportunities - Besides SYF, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting additional investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]
Buying Highly-Ranked Value Stocks in November and Beyond
ZACKS· 2024-11-05 19:56
The S&P 500 and the Nasdaq jumped over 1% through morning trading on election day. Wall Street has been generally pleased by earnings results thus far, and the outlook for more rate cuts remains intact even if the Fed will likely cut at a slower pace.The S&P 500 held the line at its 50-day moving average. There could, without a doubt, be more volatility and selling in the near term. It is worth remembering that the Nasdaq has soared 75% in the last two years, with the benchmark up 52%.Thankfully, Wall Stree ...
JCPenney and Synchrony Extend Long-Term Financing Partnership with Multi-Year Contract Renewal
Prnewswire· 2024-10-30 11:00
Core Insights - Synchrony has extended its nearly 25-year partnership with JCPenney to include new financing options, specifically the Synchrony Pay Later program, enhancing customer purchasing flexibility [1][2][4] Financing Options - The new Synchrony Pay Later option allows customers to finance fine jewelry purchases over $300 with installment payments of 6, 12, or 24 months, available both in-store and online [2][3] - Customers can apply for Synchrony Pay Later by scanning a QR code at checkout, completing the application on their device, and if approved, selecting their loan terms and using a virtual card for immediate purchase [3] Customer Engagement - JCPenney's CFO highlighted that the partnership with Synchrony has fostered customer loyalty, with cardholders visiting more frequently and spending more per trip compared to other customers [4] - Synchrony aims to help partners like JCPenney build long-term customer relationships that extend beyond single purchases, reflecting their commitment to partner growth and transformation [4] Company Background - JCPenney serves diverse working families in the U.S. and Puerto Rico, offering a wide range of products including fashion, home goods, and jewelry, supported by over 50,000 associates [6] - The company celebrated its 120th anniversary in 2022, emphasizing its legacy of customer connection through shopping and community engagement [7] Synchrony Overview - Synchrony is a leading consumer financial services company, providing a comprehensive suite of digitally enabled products across various industries, including retail and healthcare [8][9]
New Synchrony Research Finds Pet Parents Are Equally as Concerned About the Cost of Specialty Veterinary Care as their Pet's Potential Outcome
Prnewswire· 2024-10-29 13:00
Core Insights - The Synchrony "Veterinary Specialty Care Study" highlights significant concerns among pet parents regarding the costs associated with specialty and emergency veterinary care, indicating a need for improved communication between general practice and specialty veterinary teams [1][4]. Financial Concerns - 72% of pet parents express high levels of concern about the financial implications of specialty care, with half feeling stressed by bills up to $1,000 and 81% stressed if costs rise to $2,500 [3]. - Nearly 50% of pet parents underestimate the costs of pet care, with unexpected emergency care contributing to this miscalculation [5]. Knowledge Gaps - Over half (54%) of pet parents report having little to no knowledge about specialty care, which underscores the need for better education and communication from veterinarians [3][6]. - Only 25% of specialists believe that pet parents have realistic expectations regarding the costs of care [3]. Communication and Education - The study emphasizes the importance of proactive communication about specialty care costs and available payment options, as 63% of pet parents want this information early in the process [5][6]. - Many pet parents (38%) research costs before seeking specialty care, and 63% go directly to emergency vets without a referral, highlighting the need for accessible information on payment options [7]. CareCredit Insights - CareCredit has been a financing option for pet parents for 30 years, available at over 25,000 veterinary locations, allowing for real-time prequalification and instant credit decisions [8]. - CareCredit offers various financing options, including deferred interest plans and reduced APR for longer-term payments, which can help alleviate financial stress for pet parents [8][9]. Study Methodology - The study involved 305 pet parents, including 255 who visited specialty or emergency veterinarians in the past year, and 118 veterinarians providing emergency or specialty care [10].